|
Share-Based Compensation (Details 2) (USD $)
|
12 Months Ended |
1 Months Ended |
|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Apr. 30, 2012
|
Aug. 31, 2014
|
Dec. 02, 2013
|
| Number of Options |
|
|
|
|
|
|
| Exercised (in shares) |
3,446,585 |
4,596,761 |
194,721 |
|
|
|
| Weighted average remaining contractual term |
|
|
|
|
|
|
| Outstanding at the end of the period |
5 years 6 months 29 days |
|
|
|
|
|
| Aggregate Intrinsic value of options |
|
|
|
|
|
|
| Exercised |
$ 23,679,729 |
|
|
|
|
|
| Outstanding at the end of the period |
25,776,635 |
|
|
|
|
|
| E-House Plan | Share Options: |
|
|
|
|
|
|
| Number of Options |
|
|
|
|
|
|
| Outstanding at the beginning of the period (in shares) |
12,949,951 |
|
|
|
|
|
| Exercised (in shares) |
(3,446,585) |
|
|
|
|
|
| Forfeited (in shares) |
(26,662) |
|
|
|
|
|
| Outstanding at the end of the period (in shares) |
9,476,704 |
12,949,951 |
|
|
|
|
| Vested and expected to vest at the end of the period (in shares) |
9,476,704 |
|
|
|
|
|
| Exercisable at the end of the period (in shares) |
9,476,704 |
|
|
|
|
|
| Weighted Average Exercise Price |
|
|
|
|
|
|
| Outstanding at the beginning of the period (in dollars per share) |
$ 4.25 |
|
|
|
|
|
| Exercised (in dollars per share) |
$ 3.49 |
|
|
|
|
|
| Forfeited (in dollars per share) |
$ 4.94 |
|
|
|
|
|
| Outstanding at the end of the period (in dollars per share) |
$ 4.52 |
4.25 |
|
|
|
|
| Vested and expected to vest at the end of the period (in dollars per share) |
$ 4.52 |
|
|
|
|
|
| Exercisable at the end of the period (in dollars per share) |
$ 4.52 |
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
|
|
|
|
| Vested and expected to vest at the end of the period |
5 years 6 months 29 days |
|
|
|
|
|
| Exercisable at the end of the period |
5 years 6 months 29 days |
|
|
|
|
|
| Aggregate Intrinsic value of options |
|
|
|
|
|
|
| Exercised |
23,679,729 |
25,248,554 |
436,259 |
|
|
|
| Outstanding at the end of the period |
|
140,247,969 |
|
|
|
|
| Vested and expected to vest at the end of the period |
25,776,635 |
|
|
|
|
|
| Exercisable at the end of the period |
25,776,635 |
|
|
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Compensation expense |
5,950,940 |
12,817,935 |
17,157,015 |
|
|
|
| E-House Plan | Restricted Shares: |
|
|
|
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Total fair value of restricted shares vested |
6,094,602 |
5,612,379 |
9,127,103 |
|
|
|
| Compensation expense |
6,174,583 |
5,668,460 |
9,348,941 |
|
|
|
| Total unrecognized compensation expense |
20,310,709 |
|
|
|
|
|
| Weighted-average period over which cost is expected to be recognized |
2 years 5 months 5 days |
|
|
|
|
|
| Leju Plan | Share Options: |
|
|
|
|
|
|
| Number of Options |
|
|
|
|
|
|
| Outstanding at the beginning of the period (in shares) |
6,592,000 |
|
|
|
|
|
| Replaced by Restricted Share |
(60,000) |
|
|
|
|
|
| Exercised (in shares) |
(266,201) |
|
|
|
|
|
| Forfeited (in shares) |
(132,000) |
|
|
|
|
|
| Outstanding at the end of the period (in shares) |
6,133,799 |
6,592,000 |
|
|
|
|
| Vested and expected to vest at the end of the period (in shares) |
5,943,719 |
|
|
|
|
|
| Exercisable at the end of the period (in shares) |
1,867,132 |
|
|
|
|
|
| Weighted Average Exercise Price |
|
|
|
|
|
|
| Outstanding at the beginning of the period (in dollars per share) |
$ 4.60 |
|
|
|
|
|
| Replaced by Restricted Share (in dollars per share) |
$ 4.60 |
|
|
|
|
|
| Exercised (in dollars per share) |
$ 4.60 |
|
|
|
|
|
| Forfeited (in dollars per share) |
$ 4.60 |
|
|
|
|
|
| Outstanding at the end of the period (in dollars per share) |
$ 4.60 |
4.60 |
|
|
|
|
| Vested and expected to vest at the end of the period (in dollars per share) |
$ 4.60 |
|
|
|
|
|
| Exercisable at the end of the period (in dollars per share) |
$ 4.60 |
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
|
|
|
|
| Outstanding at the end of the period |
8 years 11 months 1 day |
|
|
|
|
|
| Vested and expected to vest at the end of the period |
8 years 11 months 1 day |
|
|
|
|
|
| Exercisable at the end of the period |
8 years 11 months 1 day |
|
|
|
|
|
| Aggregate Intrinsic value of options |
|
|
|
|
|
|
| Exercised |
1,668,693 |
|
|
|
|
|
| Outstanding at the end of the period |
37,784,202 |
|
|
|
|
|
| Vested and expected to vest at the end of the period |
36,613,309 |
|
|
|
|
|
| Exercisable at the end of the period |
11,501,535 |
|
|
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Weighted-average grant-date fair value of options granted (in dollars per share) |
|
|
|
|
|
$ 2.21 |
| Compensation expense |
4,525,552 |
381,874 |
|
|
|
|
| Total unrecognized compensation expense |
8,676,222 |
|
|
|
|
|
| Weighted-average period over which cost is expected to be recognized |
1 year 11 months 1 day |
|
|
|
|
|
| Leju Plan | Restricted Shares: |
|
|
|
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Total fair value of restricted shares vested |
486,200 |
0 |
0 |
|
|
|
| Compensation expense |
4,923,226 |
34,758 |
|
|
|
|
| Total unrecognized compensation expense |
9,699,247 |
|
|
|
|
|
| Weighted-average period over which cost is expected to be recognized |
1 year 10 months 17 days |
|
|
|
|
|
| CRIC Plan | Share Options: |
|
|
|
|
|
|
| Aggregate Intrinsic value of options |
|
|
|
|
|
|
| Exercised |
|
|
750,115 |
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Compensation expense |
|
|
8,532,772 |
0 |
|
|
| CRIC Plan | Restricted Shares: |
|
|
|
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Total fair value of restricted shares vested |
|
|
130,000 |
|
|
|
| Compensation expense |
|
|
54,688 |
|
|
|
| Scepter Plan | Share Options: |
|
|
|
|
|
|
| Number of Options |
|
|
|
|
|
|
| Granted (in shares) |
455,000 |
|
|
|
|
|
| Forfeited (in shares) |
(5,000) |
|
|
|
|
|
| Outstanding at the end of the period (in shares) |
450,000 |
|
|
|
|
|
| Vested and expected to vest at the end of the period (in shares) |
449,526 |
|
|
|
|
|
| Weighted Average Exercise Price |
|
|
|
|
|
|
| Granted (in dollars per share) |
$ 3.30 |
|
|
|
$ 3.30 |
|
| Outstanding at the end of the period (in dollars per share) |
$ 3.30 |
|
|
|
|
|
| Vested and expected to vest at the end of the period (in dollars per share) |
$ 3.30 |
|
|
|
|
|
| Exercisable at the end of the period (in dollars per share) |
$ 3.30 |
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
|
|
|
|
| Granted |
10 years |
|
|
|
|
|
| Outstanding at the end of the period |
9 years 7 months 6 days |
|
|
|
|
|
| Vested and expected to vest at the end of the period |
9 years 7 months 6 days |
|
|
|
|
|
| Exercisable at the end of the period |
9 years 7 months 6 days |
|
|
|
|
|
| Additional disclosure |
|
|
|
|
|
|
| Compensation expense |
66,820 |
|
|
|
|
|
| Total unrecognized compensation expense |
$ 439,892 |
|
|
|
|
|
| Weighted-average period over which cost is expected to be recognized |
2 years 7 months 6 days |
|
|
|
|
|